Paclitaxel Potentiates the Anticancer Effect of Cetuximab by Enhancing Antibody-Dependent Cellular Cytotoxicity on Oral Squamous Cell Carcinoma Cells In Vitro

Administration of cetuximab (C-mab) in combination with paclitaxel (PTX) has been used for patients with head and neck squamous cell carcinoma (SCC) clinically. In this study, we attempted to clarify the molecular mechanisms of the enhancing anticancer effect of C-mab combined with PTX on oral SCC c...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Mol Sci
Main Authors: Sawatani, Yuta, Komiyama, Yuske, Nakashiro, Koh-ichi, Uchida, Daisuke, Fukumoto, Chonji, Shimura, Michiko, Hasegawa, Tomonori, Kamimura, Ryouta, Hitomi-Koide, Masayo, Hyodo, Toshiki, Kawamata, Hitoshi
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7503545/
https://ncbi.nlm.nih.gov/pubmed/32878053
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms21176292
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados